n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with angiotensin ii in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auguet, M; Chabrier, PE; Zerrouk, A | 1 |
Baber, SR; Hyman, AL; Kadowitz, PJ | 1 |
Helle, F; Iversen, BM; Vågnes, ØB | 1 |
Guo, C; Guo, RW; Liu, H; Qi, F; Wang, XM; Yang, LX; Ye, JS | 1 |
Cha, SA; Gao, S; Kim, SH; Park, BM | 1 |
5 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and angiotensin ii
Article | Year |
---|---|
Augmented endothelium-dependent contraction to angiotensin II in the SHR aorta: role of an inducible cyclooxygenase metabolite.
Topics: Angiotensin II; Animals; Aorta, Thoracic; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Cycloheximide; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium, Vascular; Enzyme Induction; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Male; Muscle Contraction; Nitrobenzenes; Piroxicam; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Synthesis Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Time Factors; Vasoconstrictor Agents | 1998 |
Role of COX-1 and -2 in prostanoid generation and modulation of angiotensin II responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Angiotensin II; Animals; Arachidonic Acid; Blood Pressure; Cardiac Catheterization; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Isoenzymes; Membrane Proteins; Nitrobenzenes; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Circulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension.
Topics: Angiotensin II; Animals; Arterioles; Calcium; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Hypertension, Renovascular; Kidney; Male; Nitrobenzenes; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Regional Blood Flow; RNA, Messenger; Signal Transduction; Sulfonamides | 2006 |
The effect of the expression of angiotensin II on extracellular matrix metalloproteinase inducer (EMMPRIN) in macrophages is mediated via the AT1/COX-2/PGE2 pathway.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Basigin; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Imidazoles; Losartan; Macrophages; Nitrobenzenes; Pyridines; Receptor, Angiotensin, Type 1; Signal Transduction; Sulfonamides | 2010 |
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides | 2015 |